Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Midodrine, Octreotide and Albumin in Refractory Ascites

NCT00240045 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT00240045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Midodrine, Octreotide and Albumin in Refractory Ascites
Lead sponsor
University of Alberta
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2005
Completion date
July 31, 2007
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory ascites, type 2 hepatorenal syndrome